Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations Reply

被引：0
|
作者：
Kristeleit, Rebecca [1 ]
Oza, Amit M. [2 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Oncol, London SE1 9RT, England
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E315 / E315
页数：1
相关论文
共 50 条
  • [1] Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations
    Ganguly, Shuvadeep
    Gogia, Ajay
    [J]. LANCET ONCOLOGY, 2022, 23 (07): : E314 - E314
  • [2] BRCA1 and BRCA2 Mutations in Ovarian Cancer Reply
    Zhang, Wei
    Yang, Da
    Sood, Anil K.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 360 - 361
  • [3] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [4] Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Hyman, David M.
    Spriggs, David R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 408 - 410
  • [5] Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
    Ramus, Susan J.
    Harrington, Patricia A.
    Pye, Carole
    DiCioccio, Richard A.
    Cox, Mark J.
    Garlinghouse-Jones, Kim
    Oakley-Girvan, Ingrid
    Jacobs, Ian J.
    Hardy, Richard M.
    Whittemore, Alice S.
    Ponder, Bruce A. J.
    Piver, M. Steven
    Pharoah, Paul D. P.
    Gayther, Simon A.
    [J]. HUMAN MUTATION, 2007, 28 (12) : 1207 - 1215
  • [6] Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Gasowska-Bodnar, Agnieszka
    Szczylik, Cezary
    [J]. GINEKOLOGIA POLSKA, 2014, 85 (05) : 377 - 381
  • [7] Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations: Missed Opportunities Reply
    Lu, Karen H.
    [J]. OBSTETRICS AND GYNECOLOGY, 2010, 116 (02): : 441 - 441
  • [8] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    Smirnova, T. Yu.
    Pospekhova, N. I.
    Lyubchenko, L. N.
    Tjulandin, S. A.
    Gar'kavtseva, R. F.
    Ginter, E. K.
    Karpukhin, A. V.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (01) : 83 - 85
  • [9] Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
    Torres-Mejia, Gabriela
    Royer, Robert
    Llacuachaqui, Marcia
    Akbari, Mohammad R.
    Giuliano, Anna R.
    Martinez-Matsushita, Louis
    Angeles-Llerenas, Angelica
    Ortega-Olvera, Carolina
    Ziv, Elad
    Lazcano-Ponce, Eduardo
    Phelan, Catherine M.
    Narod, Steven A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 498 - 505
  • [10] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    T. Yu. Smirnova
    N. I. Pospekhova
    L. N. Lyubchenko
    S. A. Tjulandin
    R. F. Gar’kavtseva
    E. K. Ginter
    A. V. Karpukhin
    [J]. Bulletin of Experimental Biology and Medicine, 2007, 144 : 83 - 85
12345